Drug Makers Putting Profit Before The Elderly
The Medpage Today staff reported this week on a CNN investigation of Nuedexta, a drug approved for PseudoBulbar Affect (PBA). The investigation found PBA is being marketed aggressively to the elderly as a therapy for dementia. Even though independent studies indicate PBA is only rarely associated with dementia, Avanir, the drug’s manufacturer, has spent millions of dollars promoting […]
Big Pharma and Politics
At a rally in Kentucky, President Donald Trump said drug prices were “outrageous”. The next day, according to Kaiser Health News, the pharmaceutical industry donated more money to political campaigns than any other day this year. On March 21, eight pharma political action committees made 137 contributions to 77 politicians totaling nearly $280,000. Both Republicans and […]
Healthcare Cost
Healthcare cost is extraordinarily high in America. We spend 50-100% more per person than other developed countries. It is not because their care is better, to the contrary. Our cost is high for a number of reasons which I discussed in some detail in Health Attitude: Unraveling and Solving the Complexities of Healthcare. The media and […]
Electronic Health Records
I continue to deplore Congress for not talking about the real problem in American healthcare, the cost of delivering healthcare. Premiums and deductibles are high because the cost of healthcare delivery is high. Drug prices are in runaway price growth. When the CEO of a major drug company was asked why they keep raising prices, he said, “Because […]
The Real Problem With Healthcare
Paul Matadeen called me for an impromptu interview about the stall in the Senate healthcare legislation. Here is what I told him.
